文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒性休克随机对照试验中器官支持结局的报告:方法学综述——脓毒症器官支持研究

Reporting of Organ Support Outcomes in Septic Shock Randomized Controlled Trials: A Methodologic Review-The Sepsis Organ Support Study.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论脓毒性休克随机对照试验中器官支持时长与无器官支持天数的定义和报告高度异质且常缺失,尤其死者如何计入计算常未报告,可能影响结果解读。

该研究为方法学系统综述,检索MEDLINE via PubMed、Embase、Cochrane Central Register of Controlled Trials和Web of Science,纳入2004年1月至2018年3月发表的28项涉及脓毒性休克成人、评估血流动力学支持、呼吸支持或肾脏替代治疗器官支持时长和/或无器官支持天数的随机对照试验。结果显示,器官支持时长和无器官支持天数结局在血流动力学支持中分别有17项和15项随机对照试验报告,呼吸支持均为15项,肾脏替代治疗分别为5项和9项。死者被纳入器官支持时长计算的比例在血流动力学支持为13/14(93%),呼吸支持为9/10(90%)。无器官支持天数定义在血流动力学支持、呼吸支持和肾脏替代治疗中分别仅6/15(40%)、8/15(53%)和6/9(67%)的随机对照试验报告,其中一半将死者赋值为「0」,另一半按存活且无器官支持每天计1分至预设时间点。结论强调这些结局指标定义和计算方法报告不频繁且异质,可能对解读产生重要影响。

要点

  • 脓毒性休克随机对照试验中器官支持时长和无器官支持天数结局报告异质且不频繁,血流动力学支持时长17项、无器官支持天数15项报告。
  • 死者被纳入器官支持时长计算的比例:血流动力学支持13/14(93%),呼吸支持9/10(90%)。
  • 无器官支持天数定义报告率低:血流动力学支持6/15(40%)、呼吸支持8/15(53%)、肾脏替代治疗6/9(67%)。
  • 报告无器官支持天数定义的试验中,一半将死者赋值为「0」,另一半按存活且无器官支持每天计1分至预设时间点。
  • 器官支持结局的定义和计算方法报告不频繁,尤其死者如何计入,可能对结果解读产生重要影响。

适用人群与场景

  • 纳入2004年1月至2018年3月发表的随机对照试验,涉及脓毒性休克成人,评估血流动力学支持、呼吸支持或肾脏替代治疗的器官支持时长和/或无器官支持天数。

研究设计与关键结果

  • 研究类型为方法学系统综述,纳入28项随机对照试验,检索MEDLINE via PubMed、Embase、Cochrane Central Register of Controlled Trials和Web of Science。
  • 器官支持时长和无器官支持天数结局在血流动力学支持中分别有17项和15项随机对照试验报告,呼吸支持均为15项,肾脏替代治疗分别为5项和9项。
  • 死者被纳入器官支持时长计算:血流动力学支持13/14(93%),呼吸支持9/10(90%)。
  • 无器官支持天数定义报告:血流动力学支持6/15(40%),呼吸支持8/15(53%),肾脏替代治疗6/9(67%)。
  • 报告无器官支持天数定义的试验中,一半将死者赋值为「0」,另一半按存活且无器官支持每天计1分至预设时间点。

证据类型、等级与局限

  • 证据类型:方法学系统综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Many recent randomized controlled trials in the field of septic shock failed to demonstrate a benefit on mortality. Randomized controlled trials increasingly report organ support duration and organ support-free days as primary or secondary outcomes. We conducted a methodologic systematic review to assess how organ support outcomes were defined and reported in septic shock randomized controlled trials.

DATA SOURCES: MEDLINE via PubMed, Embase, Cochrane Central Register of Controlled Trials, and Web of Science.

STUDY SELECTION: We included randomized controlled trials published between January 2004 and March 2018 that involved septic shock adults and assessed organ support duration and/or organ support-free days for hemodynamic support, respiratory support, or renal replacement therapy.

DATA EXTRACTION: For each randomized controlled trial, we extracted the definitions of organ support duration and organ support-free days. We particularly evaluated how nonsurvivors were accounted for. Study authors were contacted to provide any missing information regarding these definitions.

DATA SYNTHESIS: We included 28 randomized controlled trials. Organ support duration and organ support-free days outcomes were reported in 17 and 15 randomized controlled trials, respectively, for hemodynamic support, 15 and 15 for respiratory support, and five and nine for renal replacement therapy. Nonsurvivors were included in the organ support duration calculation in 13 of 14 randomized controlled trials (93%) for hemodynamic support and nine of 10 (90%) for respiratory support. The organ support-free days definition for hemodynamic support, respiratory support, and renal replacement therapy was reported in six of 15 randomized controlled trials (40%), eight of 15 randomized controlled trials (53%), and six of nine randomized controlled trials (67%) reporting an organ support-free days outcome, respectively. Of these, one half assigned "0" to nonsurvivors, and the other half attributed one point per day alive free of organ support up to a predefined time point.

CONCLUSIONS: This study highlights the heterogeneity and infrequency of organ support duration/organ support-free days outcome reporting in septic shock trials. When reported, the definitions of these outcome measures and methods of calculation are also infrequently reported, in particular how nonsurvivors were accounted for, which may have an important impact on interpretation.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Bourcier S, Hindlet P, Guidet B, et al. Reporting of Organ Support Outcomes in Septic Shock Randomized Controlled Trials: A Methodologic Review-The Sepsis Organ Support Study. Crit Care Med. 2019. PMID: 30889023. doi:10.1097/CCM.0000000000003746

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。